Organoids are produced from stem cells, which can both renew themselves and generate specialized descendants, including neurons and glial cells. Under carefully controlled conditions, these cells can organize themselves into structures that resemble aspects of developing tissues. Brain organoids are particularly valuable because they allow researchers to study early neural development in a three-dimensional environment outside the body. However, most established systems have been derived from human stem cells, making them useful for investigating human biology but often difficult to manipulate genetically. Mice, by contrast, offer a much larger collection of genetic tools for tracing individual cells, altering specific genes, and linking cellular behavior to developmental outcomes. The ISTA team set out to combine the organizational advantages of organoids with the experimental precision of the mouse model.

The project was led by the Hippenmeyer group, with Melissa Stouffer, Osvaldo Miranda Romero, Florian Pauler, and Fabrizia Pipicelli as co-lead authors, alongside Carmen Streicher and Giselle Cheung. Developing the system required more than simply placing mouse stem cells in a culture dish. The researchers first established a stable mouse stem cell line and then optimized a reproducible protocol capable of generating cortical organoids across different experimental batches and cell lines. Stouffer trained in advanced three-dimensional brain organoid methods at Stanford University’s Brain Organogenesis Workshop, an experience that helped the team address the technical challenges of maintaining stem cells and producing consistently structured organoids. This groundwork was essential because variability between organoids can obscure genuine biological patterns and make developmental comparisons difficult.

The resulting structures contained cortical rosettes, organized formations that resemble aspects of the neural tissue found in the developing cerebral cortex. These rosettes appeared as dense regions along the outer edge of the organoids and were composed of neural progenitor cells, the descendants of stem cells that generate the brain’s neurons and glial cells. To test how faithfully the organoids modeled development, the researchers compared them directly with developing mouse brains rather than relying on comparisons between different species. They examined corresponding developmental stages using single-cell sequencing, a method that measures gene activity in individual cells. This approach allowed the team to determine which cell populations were present, how abundant they were, which molecular programs were active, and when particular cell types emerged or declined.

At a broad level, the organoids closely resembled the developing mouse cortex. The researchers detected similar populations of neural progenitors, neurons, and glial cells in both the organoids and living tissue. They also found that many of the molecular programs guiding development were shared. This similarity means that mouse cortical organoids can provide meaningful information about fundamental mechanisms of brain formation, including the behavior of radial glia. Radial glial cells are neural stem and progenitor cells that both produce new brain cells and provide structural support during cortical development. Their descendants eventually form the layered architecture of the cerebral cortex, a region essential for sensory processing, movement, learning, and cognition.

The most striking difference emerged when the team examined developmental timing. In the living mouse brain, cortical development follows a largely ordered sequence. Neural stem cells initially expand through symmetric divisions, in which one cell produces two similar progenitor cells. They then shift toward asymmetric divisions, generating one progenitor and one differentiating daughter cell, a transition that supports the production of neurons. After the major wave of neuron formation has ended, the production of glial cells becomes prominent. These phases are arranged in a temporal progression, allowing the developing brain to coordinate cell production with tissue growth and organization.

In the cortical organoids, the same broad cellular identities appeared, but the schedule was less tightly controlled. Neural development became temporally uncoupled: populations and programs that normally arise in sequence could overlap or appear at different relative times. The organoids preserved the overall “hour” of development but not its precise “minutes,” as the researchers describe it. The emergence of glial cells was a notable exception. In both the organoids and the mouse brain, glial development followed neuron formation, suggesting that some parts of the developmental timetable are intrinsically robust while others depend more heavily on signals from the surrounding organism. This distinction could be critical when interpreting organoid experiments involving disease-associated genes or developmental disorders.

To investigate lineage progression in greater detail, the researchers used MADM, or Mosaic Analysis with Double Markers. This genetic technique labels cells and their descendants with different fluorescent markers after specific chromosome-segregation events, enabling scientists to follow the behavior of individual progenitor cells and their lineages. The method has previously allowed the Hippenmeyer group to map the development of the mouse cortex at the level of single progenitor cells. Applying the same conceptual framework to organoids made it possible to compare how stem cells divide and produce descendants in a living brain versus an isolated three-dimensional culture. The findings indicate that self-organization alone can reproduce much of the cortical program, but cannot fully impose the orderly progression observed in vivo.

The likely explanation is the absence of the stem-cell niche. In the living brain, neural progenitors do not develop in isolation. They interact with neighboring cells, blood vessels, signaling molecules, growth factors, extracellular structures, and mechanical forces. These external inputs can influence when stem cells divide, when they switch from producing neurons to producing glia, and how newly generated cells are positioned. Organoids contain some internal communication and can organize themselves without direct instruction, but they lack many of the systemic signals supplied by an intact organism. The study therefore identifies not only what cortical organoids can reproduce, but also which developmental processes remain dependent on environmental context.

The new model gives researchers a controlled platform for testing how genetic mutations, biochemical signals, or physical conditions affect cortical development. It may help clarify why changes in the regulation of neural stem cells lead to unusually small or large brains and could reveal which developmental stages are most vulnerable to disruption. The researchers’ next goal is to recreate selected components of the stem-cell niche within the organoids by adding factors found in the mouse brain. If those interventions restore a more linear developmental sequence, they could improve the precision of organoid models and make them more useful for studying neurological disease. The work establishes a clear benchmark for future organoid research: similarity to a real brain should be measured not only by the cell types present, but also by the timing, lineage relationships, and environmental signals that bring those cells into existence.

Subject of Research: Lab-produced tissue samples

Article Title: Temporal Uncoupling of Radial Glia Lineage Progression in Cortical Organoid

Web References: Nature article; ISTA Hippenmeyer Group

References: Nature; DOI: 10.1038/s41586-026-10916-7

Image Credits: © Stouffer et al. / Nature

Keywords

Cortical organoids, brain organoids, mouse models, cerebral cortex, neural stem cells, radial glia, brain development, neuroscience, single-cell sequencing, MADM, tissue cultures, organ development

A groundbreaking study spearheaded by Dr. Tran Tuoc and colleagues has uncovered a hitherto unknown genetic culprit in primary microcephaly: haploinsufficiency of EXOSC10, a key component of the RNA exosome complex. Through comprehensive genomic screening of patients exhibiting cortical malformations, the team identified de novo mutations in the EXOSC10 gene, marking a pivotal expansion of the genetic landscape associated with microcephaly. This discovery propels new understandings regarding the downstream consequences of RNA regulation disruptions on cerebral cortex development.

To decipher how these EXOSC10 mutations translate into pathological phenotypes, the researchers engineered conditional mouse models mirroring the human genetic aberrations. These models revealed that partial loss of EXOSC10 function precipitates premature differentiation of neural stem cells into neurons. This shift diminishes the progenitor pool early in brain development, culminating in a smaller cerebral cortex—an anatomical hallmark that closely parallels patients’ clinical presentations. This phenotypic recapitulation underscores the critical role of EXOSC10 dosage in maintaining neural stem cell populations.

Delving deeper into the molecular underpinnings, the study utilized RNA sequencing and RNA immunoprecipitation techniques to probe transcriptomic alterations caused by compromised EXOSC10 activity. It became evident that EXOSC10 normally mediates the degradation of specific messenger RNAs integral to the Sonic hedgehog (Shh) signaling pathway, including Scube1 and Scube3 transcripts. When EXOSC10 function is impaired, these transcripts aberrantly accumulate, provoking sustained hyperactivation of Shh signaling—a pathway with established roles in neurodevelopmental patterning.

The consequence of unchecked Shh activity, driven by deregulated RNA decay, was elucidated further through experimental modulation in mutant mice. Attenuation of Shh signaling partially restored cerebral cortex size, effectively rescuing the microcephaly phenotype. This critical functional validation positions excessive Shh pathway stimulation, secondary to disrupted RNA turnover, as the primary mechanism fueling reduced cortical growth in EXOSC10 haploinsufficiency.

This research elegantly introduces a previously unappreciated nexus between post-transcriptional RNA degradation and canonical signaling cascades in brain development. By highlighting the indispensable role of EXOSC10 within the RNA exosome, it implicates RNA homeostasis as a linchpin in neural progenitor fate decisions. The balance of RNA synthesis and decay emerges as a fundamental regulatory axis requisite for proper cortical expansion and neural diversity.

Beyond its immediate genetic revelations, this study invites a paradigm shift in how neurodevelopmental disorders are conceptualized. Traditional views have largely centered on transcriptional control and signaling pathway mutations. In contrast, these findings underscore the profound influence of RNA metabolism, and by extension, RNA surveillance and decay pathways, in shaping developmental trajectories. This could open fertile ground for novel diagnostic and therapeutic strategies targeting RNA regulatory machinery.

The translational significance extends to broadening the phenotypic spectrum of primary microcephaly by incorporating EXOSC10 mutations. It encourages systematic screening of RNA exosome components in patients presenting with cortical malformations, refining genotype-phenotype correlations. Moreover, the genetically engineered mouse models developed offer a powerful platform to explore temporally and spatially restricted gene functions during neocortical development.

Methodologically, the study exemplifies the synergy of state-of-the-art approaches—from high-throughput genome sequencing to sophisticated genetic manipulation and transcriptomic analyses. This integrative strategy allowed the team to traverse from patient genetics to mechanistic insights and back to an in vivo context, exemplifying modern precision neuroscience research. The investigative depth sets a new benchmark for elucidating complex neurodevelopmental disorders.

The implication of Sonic hedgehog signaling in this context also invites re-examination of this pathway’s roles beyond traditional morphogenetic patterning. The Shh pathway’s aberrant activation as a downstream event in RNA decay impairment suggests a multifaceted interplay between transcriptional, post-transcriptional, and signaling networks orchestrating brain architecture. Understanding these interactions might reveal novel intervention points for correcting developmental abnormalities.

Taken together, these discoveries not only deepen the fundamental biological understanding of how cerebral cortex size and structure are regulated but also spotlight RNA degradation as a critical developmental check point. This insight reshapes how researchers and clinicians might approach the etiology and treatment of primary microcephaly and related neurodevelopmental pathologies. As such, the study stands as a landmark contribution shedding light on previously concealed genetic and molecular etiologies.

In sum, Dr. Tran Tuoc’s team has articulated a compelling narrative where EXOSC10, through its role in RNA decay, restricts unwarranted Shh signaling to preserve the neural stem cell reservoir and promote normal cortical formation. This intricately choreographed process exemplifies the complexity of gene regulation in neurodevelopment and heralds new horizons in understanding and potentially remedying brain malformations associated with RNA metabolism disruptions.

Subject of Research: Animals
Article Title: EXOSC10 Haploinsufficiency Causes Primary Microcephaly by Derepression of Sonic Hedgehog Signalling
News Publication Date: 24-Oct-2025
Web References: 10.1093/brain/awaf405
Image Credits: © RUB, Marquard
Keywords: Genetics, Developmental biology

Fetal growth restriction, a major complication affecting pregnancies worldwide, frequently results from inadequate oxygen supply to the fetus. This condition triggers physiological adaptations aimed at safeguarding critical organs such as the brain, a phenomenon widely recognized as the brain-sparing effect. Here, blood flow prioritizes the cerebral circulation, inducing sustained vasodilation within brain vessels to preserve oxygen delivery despite systemic hypoxic stress. While extensively documented, the downstream consequences of this adaptive response on the integrity of the blood-brain barrier remain largely enigmatic. The current study steps boldly into this knowledge gap.

Crucially, the blood-brain barrier serves as a highly selective interface between the cerebral vasculature and neural tissue, maintaining a tightly regulated environment essential for optimal brain function. Disruptions in BBB permeability can expose the delicate neural milieu to potentially harmful circulating substances, inflammatory mediators, and pathogens, thereby increasing vulnerability to neurological injury. By investigating neonatal guinea pigs gestated under chronic hypobaric hypoxia, researchers provide compelling evidence suggesting increased BBB permeability, highlighting previously uncharted dimensions of perinatal brain vulnerability linked to gestational environmental stress.

The experimental design employed in this research involved exposing pregnant guinea pigs to hypobaric hypoxia—a simulation of high-altitude low-oxygen conditions—throughout gestation. Neonates were then assessed for changes in BBB permeability within the cerebral cortex using advanced histological and molecular techniques. Observations indicate a marked increase in BBB permeability in the hypoxia-exposed group compared to controls, implicating gestational hypoxia as a potent modulator of neonatal neurovascular integrity.

Such findings resonate deeply within the neurodevelopmental discourse, as they underscore the trade-offs embedded in fetal adaptations to hypoxic stress. While the brain-sparing mechanism ensures oxygen delivery, the resultant sustained cerebral vasodilation may consequently impair the selective shield provided by the BBB. This compromised barrier function posits a risk factor for secondary neuropathology, including neuroinflammation and long-term cognitive deficits, often reported in infants born after FGR complicated pregnancies.

The molecular underpinnings of these alterations appear linked to hypoxia-induced endothelial dysfunction within cerebral microvasculature. Hypoxia can disrupt tight junction proteins such as occludin and claudins, crucial for maintaining BBB impermeability, and elevate the expression of vascular endothelial growth factor (VEGF), promoting angiogenesis but concurrently increasing vascular permeability. By elucidating these pathways in vivo, this study adds a critical layer of mechanistic understanding to how chronic prenatal hypoxia remodels the neonatal brain’s protective landscape.

Furthermore, the study’s utilization of the guinea pig model is particularly insightful due to its closer resemblance to human placentation and brain development trajectories compared to more commonly used rodents. This parallels human fetal development more accurately, strengthening the clinical relevance of the findings. The translational potential is significant, offering new perspectives for therapeutic interventions targeting BBB integrity in at-risk neonates gestated under hypoxic conditions.

Beyond the immediate implications for neonatal neuropathology, these revelations invite deeper exploration into preventive strategies during pregnancy. Interventions such as maternal oxygen therapy, pharmacological agents that stabilize endothelial function, or modulation of inflammatory cascades may hold promise in mitigating the adverse effects of gestational hypoxia on the developing brain. Early detection and monitoring of BBB permeability could emerge as critical components of neonatal care protocols in the future.

The consequences of increased BBB permeability reach beyond infancy, as compromised barrier function often sets the stage for delayed neurodevelopmental disorders, including cerebral palsy, learning disabilities, and behavioral abnormalities. This research thus aligns with broader efforts to connect prenatal insults with lifelong neurological outcomes, reinforcing the need for perinatal neuroprotective strategies.

Moreover, the study raises intriguing questions about the balance between physiological adaptation and pathological vulnerability during fetal development. It illuminates how compensatory mechanisms like cerebral vasodilation, designed to protect the brain, might simultaneously sow the seeds for neurovascular compromise. This paradox challenges existing paradigms and invites a reevaluation of fetal adaptive responses in light of long-term brain health.

Advancements in imaging and molecular diagnostics now enable a closer examination of subtle pathophysiological changes within the fetal brain environment. Coupled with this study, these technologies could revolutionize how clinicians assess and manage pregnancies impacted by hypoxia and FGR, potentially identifying those neonates at highest risk for BBB dysfunction and tailoring interventions accordingly.

This research also has significant implications in the context of global health, where high-altitude pregnancies and hypoxia-related gestational complications remain prevalent. Understanding the mechanistic links between environmental factors and neonatal brain injury could contribute to developing region-specific maternal-fetal health policies and resource allocation aimed at minimizing the burden of neurodevelopmental disorders.

Ultimately, the study by Figueroa et al. stands as a compelling testament to the complex interplay between fetal environment and brain development. It challenges researchers and clinicians alike to consider how subtle shifts in prenatal oxygen dynamics affect the cerebral microvasculature’s integrity, urging renewed focus on the blood-brain barrier as a critical nexus in perinatal neuropathology.

As research continues to unravel the molecular dialogues between hypoxia, vascular remodeling, and neuroprotection, the quest to safeguard the developing brain in adverse gestational conditions takes a vital step forward. Future investigations building on these findings may pave the way for innovative therapies that preserve BBB function, providing hope for improved neurodevelopmental outcomes in vulnerable newborns worldwide.

In conclusion, the study’s demonstration that gestational hypoxia significantly increases blood-brain barrier permeability in the neonatal guinea pig cortex signifies a paradigm shift. It calls for heightened awareness of the delicate balance fetal adaptation must maintain and sparks urgency in addressing the neurological sequelae of hypoxia-induced BBB dysfunction. These insights hold profound implications for neonatal medicine, developmental neuroscience, and the enduring pursuit of healthier beginnings.

Subject of Research: Blood-brain barrier permeability changes induced by gestational hypoxia in neonatal cerebral cortex.

Article Title: Gestational hypoxia increases brain-blood barrier permeability in the neonatal cerebral cortex of Guinea pigs.

Article References:
Figueroa, E.G., Paz, A.A., Jiménez, T.A. et al. Gestational hypoxia increases brain-blood barrier permeability in the neonatal cerebral cortex of Guinea pigs. Pediatr Res (2025). https://doi.org/10.1038/s41390-025-04345-x

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41390-025-04345-x